Nature Communications (Jan 2019)

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients

  • Koen Venken,
  • Peggy Jacques,
  • Céline Mortier,
  • Mark E. Labadia,
  • Tine Decruy,
  • Julie Coudenys,
  • Kathleen Hoyt,
  • Anita L. Wayne,
  • Robert Hughes,
  • Michael Turner,
  • Sofie Van Gassen,
  • Liesbet Martens,
  • Dustin Smith,
  • Christian Harcken,
  • Joseph Wahle,
  • Chao-Ting Wang,
  • Eveline Verheugen,
  • Nadia Schryvers,
  • Gaëlle Varkas,
  • Heleen Cypers,
  • Ruth Wittoek,
  • Yves Piette,
  • Lieve Gyselbrecht,
  • Serge Van Calenbergh,
  • Filip Van den Bosch,
  • Yvan Saeys,
  • Gerald Nabozny,
  • Dirk Elewaut

DOI
https://doi.org/10.1038/s41467-018-07911-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

The role of innate T cell subsets in the pathogenesis of spondyloarthritis (SpA) is not well understood. Here, the authors examine the role of invariant natural killer T (iNKT) and γδ-T cells in SpA and show that disease-derived iNKT and γδ-T cells have unique and Th17-skewed phenotype and gene expression profiles within inflamed joints.